[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.134.98. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
September 26, 2017

Using Big Data to Reveal Chronic Respiratory Disease Mortality Patterns and Identify Potential Public Health Interventions

Author Affiliations
  • 1GlaxoSmithKline, Philadelphia, Pennsylvania
  • 2Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health, Lexington
JAMA. 2017;318(12):1112-1114. doi:10.1001/jama.2017.11746

Big data has been defined as “[e]xtremely large data sets that may be analyzed computationally to reveal patterns, trends, and associations, especially relating to human behaviour and interactions.”1 This term has been increasingly used for biomedical research. In this issue of JAMA, Dwyer-Lindgren and colleagues2 analyzed a data set that meets this definition to estimate differences in mortality from chronic respiratory diseases among US counties, based on small area estimation models involving more than 80 million US decedents over a 35-year period, from 1980 through 2014.3 The data presented provide interesting and important insights into chronic respiratory diseases and may identify some areas amenable to public health intervention.2

×